Skip to main content

ETHZilla Corp

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

FRMM$2.82-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

ETHZilla CORPORATION,formerly180 LIFE SCIENCES CORP. AND SUBSIDIARIES

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

For The Three and Nine Months Ended September 30, 2025 and 2024

Series B Preferred · Common Stock · Treasury · Additional Paid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders' Equity
Shares · Amount · Shares · Amount · Stock · Capital · Income · Deficit · (Deficit)
Balance - January 1, 20251,000,000$100317,705$32$-$153,692,041$(2,916,918)$(141,523,344)$9,251,911
Cancelled shares--(239)------
Shares issued for settlement of liabilities--24,3172-309,998--310,000
Stock-based compensation--45,0005-577,579--577,584
Conversion of Series B Convertible Preferred Stock(1,000,000)(100)131,80013-87---
Comprehensive loss:
Net loss-------(2,369,232)(2,369,232)
Other comprehensive loss------(64,691)-(64,691)
Balance - March 31, 2025--518,58352-154,579,705(2,981,609)(143,892,576)7,705,572
Shares issued for settlement of liabilities--50,9715-441,401--441,406
Stock-based compensation--34,3733-103,621--103,624
Commitment to repurchase common stock----(1,000,000)---(1,000,000)
Comprehensive loss:
Net loss-------(1,726,604)(1,726,604)
Other comprehensive loss------(143,435)-(143,435)
Balance - June 30, 2025--603,92760(1,000,000)155,124,727(3,125,044)(145,619,180)5,380,563
Cancelled shares--(131,800)(13)1,000,000(999,987)---
Shares issued for cash and warrants, net--15,545,8211,555-458,129,883--458,131,438
Exercise of warrants--504,74350-5,605,656--5,605,706
Cashless exercise of warrants--132,00013-(13)---
Exercise of options--8,0001-74,319--74,320
Stock based compensation-----208,241,459--208,241,459
Share repurchases----(16,121,428)---(16,121,428)
Adjustment related to reverse stock split--4,595------
Comprehensive loss:
Net loss-------(216,742,056)(216,742,056)
Other comprehensive income------567,363-567,363
Balance - September 30, 2025-$-16,667,286$1,666$(16,121,428)$826,176,044$(2,557,681)$(362,361,236)$445,137,365
Balance - January 1, 2024-$-53,476$5$-$130,117,258$(2,901,339)$(127,343,657)(127,733)
Shares issued from exercise of August 2023 pre-funded warrants--25,7213-486--489
Adjustment related to reverse stock split--6,0851-(1)---
Stock-based compensation-----236,062--236,062
Comprehensive loss:
Net loss-------(1,069,744)(1,069,744)
Other comprehensive income------6,460-6,460
Balance - March 31, 2024--85,2829-130,353,805(2,894,879)(128,413,401)(954,466)
Shares issued for settlement of liabilities--8,8821-523,250--523,251
Stock based compensation-----22,308--22,308
Comprehensive income (loss):
Net income-------11,78111,781
Other comprehensive loss------(20,861)-(20,861)
Balance -June 30, 2024-$-94,164$10$-$130,899,363$(2,915,740)$(128,401,620)$(417,987)
Shares issued for settlement of liabilities--8,5341-190,010--190,011
Stock based compensation-----16,456--16,456
Warrants issued for asset acquisition-----4,849,346--4,849,346
Comprehensive income (loss):
Net loss-------(836,720)(836,720)
Other comprehensive loss------(67,332)-(67,332)
Balance -September 30, 2024-$-102,698$11$-$135,955,175$(2,983,072)$(129,238,340)$3,733,774
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.